Michael Murninkas

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Atrial Fibrillation

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Shira Burg, Or Levi, Sigal Elyagon, Shir Shapiro, Michael Murninkas, Sharon Etzion, Gideon Gradwohl, Daria Makarovsky, Alexandra Lichtenstein, Yaara Gordon, Bernard Attali, Yoram Etzion
The SK4 channel allosteric blocker, BA6b9, reduces atrial fibrillation substrate in rats with reduced ejection fraction. PNAS nexus 3 (5) (2024)
Shira Burg, Or Levi, Sigal Elyagon, Shir Shapiro, Michael Murninkas, Sharon Etzion, Gideon Gradwohl, Daria Makarovsky, Alexandra Lichtenstein, Yaara Gordon, Bernard Attali, Yoram Etzion
The SK4 channel allosteric blocker, BA6b9, reduces atrial fibrillation substrate in rats with reduced ejection fraction. PNAS nexus 3 (5) (2024)
Shira Burg, Shir Shapiro, Asher Peretz, Elvira Haimov, Boris Redko, Adva Yeheskel, Luba Simhaev, Hamutal Engel, Avi Raveh, Ariel Ben-Bassat, Michael Murninkas, Rotem Polak, Yoni Haitin, Yoram Etzion, Bernard Attali
Allosteric inhibitors targeting the calmodulin-PIP2 interface of SK4 K + channels for atrial fibrillation treatment. Proceedings of the National Academy of Sciences of the United States of America 119 (34) (2022)